PerkinElmer (PKI) to Acquire Nexcelom Bioscience for $260M

Go back to PerkinElmer (PKI) to Acquire Nexcelom Bioscience for $260M

PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience

May 12, 2021 4:05 PM EDT

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire... More